TELA Bio (TELA) Return on Invested Capital (2025 - 2026)
TELA Bio's quarterly Return on Invested Capital came in at 0.01% in Q1 2026, up 10.78% quarter-over-quarter from 0.01% in Q4 2025.
TELA Bio has reported Return on Invested Capital for 2 years, with the latest figure at 0.01% in Q1 2026.
- For the quarter ending Q1 2026, Return on Invested Capital changed N/A year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed N/A YoY), and the FY2025 full-year result was 0.01%, changed 0.0% from the prior year.
- Return on Invested Capital for Q1 2026 stood at 0.01%, up from 0.01% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.01% in Q1 2026, with the low at 0.01% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.00% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.00% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.00% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.00% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.00% |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |